Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
Shattuck Labs, Inc.
Shattuck Labs, Inc.
Orca Biosystems, Inc.
Gamida Cell ltd
NextCure, Inc.
Novartis
Geron Corporation
Takeda
Incyte Corporation
Incyte Corporation
Bristol-Myers Squibb
Amgen
American Regent, Inc.
Celgene
Fujifilm Pharmaceuticals U.S.A., Inc.
Aprea Therapeutics
BerGenBio ASA
Syros Pharmaceuticals
Ensoma
Celgene
Takeda
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Amgen
Ono Pharmaceutical Co. Ltd
IGF Oncology, LLC
Kyowa Kirin Co., Ltd.
Pfizer
Sumitomo Pharma America, Inc.
Takeda
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Amgen
Celgene
Fate Therapeutics
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
GlaxoSmithKline
Novartis
GT Biopharma, Inc.
Merck Sharp & Dohme LLC
Takeda
Kiadis Pharma
Celgene
Geron Corporation
Merck Sharp & Dohme LLC
Gamida Cell ltd
Nohla Therapeutics, Inc.
Kiadis Pharma